Revefenacin for the treatment of chronic obstructive pulmonary disease
Author:
Affiliation:
1. Department of Endocrinology, Central Hospital of Linyi City, Yishui Shandong, China
2. Department of Pharmaceutical, Central Hospital of Linyi City, Yishui, Shandong, China
Funder
paper was not funded
Publisher
Informa UK Limited
Subject
Pharmacology (medical),General Pharmacology, Toxicology and Pharmaceutics,General Medicine
Link
https://www.tandfonline.com/doi/pdf/10.1080/17512433.2019.1587292
Reference40 articles.
1. Impact of heart failure and other comorbidities on mortality in patients with chronic obstructive pulmonary disease: a register-based, prospective cohort study
2. Occupational Exposures Are Associated with Worse Morbidity in Patients with Chronic Obstructive Pulmonary Disease
3. Association between exposure to ambient particulate matter and chronic obstructive pulmonary disease: results from a cross-sectional study in China
4. Chronic obstructive pulmonary disease associated with biomass fuel use in women: a systematic review and meta-analysis
5. Associations of Ambient Air Pollution with Chronic Obstructive Pulmonary Disease Hospitalization and Mortality
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Muscarinic control of cardiovascular function in humans: a review of current clinical evidence;Clinical Autonomic Research;2024-02
2. A four-part guide to lung immunology: Invasion, inflammation, immunity, and intervention;Frontiers in Immunology;2023-03-31
3. Effect of montelukast/budesonide formoterol powder inhalation in chronic obstructive pulmonary disease;Tropical Journal of Pharmaceutical Research;2022-06-18
4. Identifying FAAH Inhibitors as New Therapeutic Options for the Treatment of Chronic Pain through Drug Repurposing;Pharmaceuticals;2021-12-28
5. The Efficacy and Safety of Revefenacin for the Treatment of Chronic Obstructive Pulmonary Disease: A Systematic Review;Frontiers in Pharmacology;2021-10-20
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3